Telbivudine for chronic hepatitis B

  • Protocol
  • Intervention



This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of telbivudine as compared with no treatment, placebo, or other antiviral drugs for chronic hepatitis B, with HBeAg-positive or HBeAg-negative status.